117 related articles for article (PubMed ID: 32603748)
1. Combined treatment of scopolamine and group III mGluR antagonist, CPPG, exerts antidepressant activity without affecting anxiety-related behaviors.
Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
Physiol Behav; 2020 Oct; 224():113034. PubMed ID: 32603748
[TBL] [Abstract][Full Text] [Related]
2. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
Podkowa K; Pilc A; Podkowa A; Sałat K; Marciniak M; Pałucha-Poniewiera A
Neuropharmacology; 2018 Oct; 141():214-222. PubMed ID: 30145321
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
Podkowa K; Podkowa A; Sałat K; Lenda T; Pilc A; Pałucha-Poniewiera A
Neuropharmacology; 2016 Dec; 111():169-179. PubMed ID: 27569995
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment.
Ebrahimi-Ghiri M; Nasehi M; Zarrindast MR
Behav Brain Res; 2019 May; 364():296-302. PubMed ID: 30797851
[TBL] [Abstract][Full Text] [Related]
5. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.
Pałucha A; Tatarczyńska E; Brański P; Szewczyk B; Wierońska JM; Kłak K; Chojnacka-Wójcik E; Nowak G; Pilc A
Neuropharmacology; 2004 Feb; 46(2):151-9. PubMed ID: 14680755
[TBL] [Abstract][Full Text] [Related]
6. Additive interaction between scopolamine and nitric oxide agents on immobility in the forced swim test but not exploratory activity in the hole-board.
Nasehi M; Mohammadi-Mahdiabadi-Hasani MH; Ebrahimi-Ghiri M; Zarrindast MR
Psychopharmacology (Berl); 2019 Nov; 236(11):3353-3362. PubMed ID: 31175384
[TBL] [Abstract][Full Text] [Related]
7. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
8. Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice.
Mohammadi-Mahdiabadi-Hasani MH; Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):827-837. PubMed ID: 35438334
[TBL] [Abstract][Full Text] [Related]
9. Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray.
Kan HW; Peng WH; Wu CC; Wang DW; Lee MT; Lee YK; Chu TH; Ho YC
Psychopharmacology (Berl); 2022 Dec; 239(12):3805-3818. PubMed ID: 36221037
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice.
Mosaffa S; Ahmadi H; Khakpai F; Ebrahimi-Ghiri M; Zarrindast MR
Psychopharmacology (Berl); 2021 Jan; 238(1):259-269. PubMed ID: 33190164
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats.
Rahmati B; Kiasalari Z; Roghani M; Khalili M; Ansari F
Pharm Biol; 2017 Dec; 55(1):958-965. PubMed ID: 28166686
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
13. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
14. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
Kaminska K; Rogoz Z
J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant and anxiolytic-like activity of sodium selenite after acute treatment in mice.
Kędzierska E; Dudka J; Poleszak E; Kotlińska JH
Pharmacol Rep; 2017 Apr; 69(2):276-280. PubMed ID: 28167456
[TBL] [Abstract][Full Text] [Related]
17. Involvement of GABAergic system in regulation of the anxiolytic- and antidepressant-like effects of Scrophularia striata extract in rats.
Kosari-Nasab M; Babri S; Fatehi-Gharehlar L; Doosti MH; Pakzad S
Pharm Biol; 2013 May; 51(5):581-8. PubMed ID: 23373710
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
Kłak K; Pałucha A; Brański P; Sowa M; Pilc A
Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis.
Amini E; Shokrnejad-Namin T; Zarrindast MR; Khakpai F
IBRO Neurosci Rep; 2024 Jun; 16():353-360. PubMed ID: 38415182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
